FDA granted rapid expanded access for daraxonrasib in previously treated metastatic PDAC, reflecting urgency and a ...

Researchers at Trinity College Dublin have published a major new review that brings fresh clarity to one of the deadliest ...

Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.

Detailed data for the gedatolisib triplet and doublet regimens will be presented at a late-breaking abstract oral session at the 2026 ASCO Annual Meeting ...

Chromosomal instability in oesophageal cancer drives immunosuppression and poor outcomes through altered immune signalling ...

The rapid evolution of advanced therapies like cell and gene therapies is reshaping the oncology landscape and challenging ...

An Aberystwyth man accused of arson died of cancer in prison after healthcare staff delayed further investigations into his ...

This is the start of a new column being written by the Tufts Medicine Lowell General Hospital Media Relations Team in ...

Positive Phase 1 data confirm MP0317’s tumor-localized CD40 activation with a favorable safety profile in patients with advanced cancer typesPharmacokinetic profile of MP0317 well suited for ...

Scientists have uncovered multiple vulnerabilities in pancreatic cancer, including a gene that helps tumors evade the immune system and a mitochondrial defect that fuels inflammation-driven growth.

Dendritic cells (DCs) have emerged in the field of cancer immunotherapy as the most potent professional antigen-presenting ...

Johnson & Johnson announced that it entered into a definitive agreement to acquire Atraverse Medical. Regeneron struck a drug pricing deal with the Trump administration to reduce prices on drugs for ...